Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
National Institutes of Health · PAR-25-104 · Research funding opportunity
Overview
Supports planning and feasibility research for cancer prevention and control clinical trials. Projects should resolve practical or scientific uncertainties needed to finalise a future trial, with an optional pilot clinical trial.
Funding amount
Up to USD 450000 in direct costs over 3 years, or USD 600000 with a pilot trial; maximum USD 225000 per year
Eligibility
Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply.
Other deadlines
Next application deadline, including permitted resubmissions: 26 October 2026. The listed 25 October 2026 date falls on a weekend; NIH extends it to the next business day. Submit by 17:00 local time of the applicant organisation. Call expiration: 26 October 2027. This is separate from the application deadline.